<p>The CD8<sup>+</sup> T cell from donor 1 pre-sensitized with nonamer aa129–aa137 (A), donor 2 pre-sensitized with aa131–aa139 (B), donor 3 pre-sensitized with aa247–aa255 (C), and donor 4 pre-sensitized with aa167–aa175 (D) or aa277–aa285 (E) were tested against partially histocompatible EBV-B cells alone or pulsed with the particular peptide using <i>in vitro</i> IFN-γ ELISPOT assay. The HLA class I alleles shared between effectors and targets are indicated in ordinate. EBV-B, Epstein-barr virus-transformed B lymphoblast.</p
<p>PBMCs were isolated from freshly or prospectively collected blood samples at M12 post-transplanta...
We have raised CD8+ cytotoxic T lymphocytes (CTL) from three Epstein-Barr virus-seropositive donors ...
We studied CD8 T cell responses against HIV-1, cytomegalovirus, Epstein-Barr virus, and influenza in...
<p>(A) EBNA2-specific responses. Top left panel: In vitro expanded, CD8-enriched polyclonal T cells ...
Epstein-Barr virus (EBV), a ubiquitous herpesvirus, induces potent HLA class I-restricted cytotoxic ...
We determined cytotoxic T lymphocyte (CTL) epitopes through screening with a computer-assisted algor...
<p>(A) Peptide-specific T cells in PBMCs from four healthy HLA-B*08:01-positive donors (a-d) were de...
<p>PBMC from four healthy donors were each re-stimulated for 8 day with three different EBV peptides...
AbstractWe investigated CD8+ T cell frequencies of five different Epstein–Barr virus-specific cytoto...
Thousands of potentially antigenic peptides are encoded by an infecting pathogen; however, only a sm...
CD8+ T cells, via their specific T-cell receptor (TCR), target infected cells when recognizing patho...
lymphocytes are present at remarkably high frequencies in healthy EBV1 individu-als and provide prot...
<p>(A, B) CD8+ T cell clones specific for epitopes from EBV latent antigens (A) or EBV lytic-cycle a...
The EBV lytic cycle targets are aligned vertically in blocs of IE, E and L antigens and responses ar...
EBV is a gammaherpesvirus that can establish both nonproductive (latent) and productive (lytic) infe...
<p>PBMCs were isolated from freshly or prospectively collected blood samples at M12 post-transplanta...
We have raised CD8+ cytotoxic T lymphocytes (CTL) from three Epstein-Barr virus-seropositive donors ...
We studied CD8 T cell responses against HIV-1, cytomegalovirus, Epstein-Barr virus, and influenza in...
<p>(A) EBNA2-specific responses. Top left panel: In vitro expanded, CD8-enriched polyclonal T cells ...
Epstein-Barr virus (EBV), a ubiquitous herpesvirus, induces potent HLA class I-restricted cytotoxic ...
We determined cytotoxic T lymphocyte (CTL) epitopes through screening with a computer-assisted algor...
<p>(A) Peptide-specific T cells in PBMCs from four healthy HLA-B*08:01-positive donors (a-d) were de...
<p>PBMC from four healthy donors were each re-stimulated for 8 day with three different EBV peptides...
AbstractWe investigated CD8+ T cell frequencies of five different Epstein–Barr virus-specific cytoto...
Thousands of potentially antigenic peptides are encoded by an infecting pathogen; however, only a sm...
CD8+ T cells, via their specific T-cell receptor (TCR), target infected cells when recognizing patho...
lymphocytes are present at remarkably high frequencies in healthy EBV1 individu-als and provide prot...
<p>(A, B) CD8+ T cell clones specific for epitopes from EBV latent antigens (A) or EBV lytic-cycle a...
The EBV lytic cycle targets are aligned vertically in blocs of IE, E and L antigens and responses ar...
EBV is a gammaherpesvirus that can establish both nonproductive (latent) and productive (lytic) infe...
<p>PBMCs were isolated from freshly or prospectively collected blood samples at M12 post-transplanta...
We have raised CD8+ cytotoxic T lymphocytes (CTL) from three Epstein-Barr virus-seropositive donors ...
We studied CD8 T cell responses against HIV-1, cytomegalovirus, Epstein-Barr virus, and influenza in...